Re Pan Pharmaceuticals Ltd; Selim v McGrath

The case of Re Pan Pharmaceuticals Ltd; Selim v McGrath involved a dispute concerning the legality of costs orders in the context of corporate liquidation. The parties included Selim, who sought to be heard in the proceedings, and McGrath, a liquidator of Pan Pharmaceuticals Ltd. The central issue was whether the court could make a costs order in favour of an interested party who attended the proceedings without being formally heard. Additionally, the case examined whether the court had jurisdiction to award costs against a non-party who was subjected to a subpoena.

The court considered several factors in determining whether to make a costs order against the party. These factors included the benefit derived by the party from the proceedings, the extent to which the party's attendance contributed to the resolution of the matter, and the fairness of the outcome. The court held that it had the jurisdiction to award costs against a non-party subjected to a subpoena, but the award was to be confined to a fixed sum unless exceptional circumstances warranted otherwise. The decision underscored the importance of ensuring that the costs orders were just and equitable, taking into account the contributions and benefits received by all parties involved.

The court concluded that it was appropriate to make a costs order in favour of the interested person who had attended the proceedings without being formally heard, provided that the order was reasonable and just. The court also determined that the award of costs against the non-party should be limited to a fixed sum, reflecting the court's discretion to ensure fairness in the proceedings. The decision provided clarity on the scope of the court's authority to award costs in complex corporate liquidation cases and highlighted the need for a balanced approach in such matters.